These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 17448033)

  • 1. PixelProstate: a simple software program for the measurement of prostate cancer volume.
    Nickels J
    Histopathology; 2007 Mar; 50(4):519-21. PubMed ID: 17448033
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging.
    Macura KJ
    Semin Roentgenol; 2008 Oct; 43(4):303-13. PubMed ID: 18774034
    [No Abstract]   [Full Text] [Related]  

  • 3. Computer modeling technology to assess extracapsular tissue coverage of whole mount sections after retropubic and laparoscopic radical prostatectomy.
    Schellhammer PF; Diaz JI; Fabrizio MD; Davis JW; Given RW; Main B; Chaganty NR; Hussein R; McKenzie R
    J Urol; 2007 Oct; 178(4 Pt 1):1301-5. PubMed ID: 17698100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
    Capitanio U; Ahyai S; Graefen M; Jeldres C; Shariat SF; Erbersdobler A; Schlomm T; Haese A; Steuber T; Heinzer H; Perrotte P; Péloquin F; Pharand D; Arjane P; Huland H; Karakiewicz PI
    Urology; 2008 Dec; 72(6):1208-11; discussion 1212-3. PubMed ID: 18692880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of the prostate at 3.0T with external phased array coil - preliminary results.
    Morakkabati-Spitz N; Bastian PJ; Gieseke J; Träber F; Kuhl CK; Wattjes MP; Müller SC; Schild HH
    Eur J Med Res; 2008 Jun; 13(6):287-91. PubMed ID: 18558555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer.
    McMahon CJ; Bloch BN; Lenkinski RE; Rofsky NM
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):363-83. PubMed ID: 19406364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial comment.
    Vollmer RT
    J Urol; 2010 May; 183(5):1814; discussion 1815. PubMed ID: 20303117
    [No Abstract]   [Full Text] [Related]  

  • 8. Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detection.
    Al-Ghamdi AM; Lockwood G; Toi A; Kulkarni GS; Evans A; Finelli A; Zlotta AR; Fleshner N
    J Urol; 2008 Apr; 179(4):1332-4. PubMed ID: 18289588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted prostate biopsy using statistical image analysis.
    Zhan Y; Shen D; Zeng J; Sun L; Fichtinger G; Moul J; Davatzikos C
    IEEE Trans Med Imaging; 2007 Jun; 26(6):779-88. PubMed ID: 17679329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
    Tanaka N; Fujimoto K; Yoshikawa M; Tanaka M; Hirao Y; Kondo H; Saito I
    Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology.
    Li R; Dai H; Wheeler TM; Sayeeduddin M; Scardino PT; Frolov A; Ayala GE
    Clin Cancer Res; 2009 May; 15(10):3568-73. PubMed ID: 19417030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic work-up of the prostate carcinoma].
    Breul J; Paul R
    MMW Fortschr Med; 2006 Nov; 148(44):26-8, 30. PubMed ID: 17619436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy.
    Weizer AZ; Shah RB; Lee CT; Gilbert SM; Daignault S; Montie JE; Wood DP
    Urol Oncol; 2007; 25(6):460-4. PubMed ID: 18047952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An image analysis method for prostate tissue classification: preliminary validation with resonance sensor data.
    Lindberg PL; Andersson BM; Bergh A; Ljungberg B; Lindahl OA
    J Med Eng Technol; 2009; 33(1):18-24. PubMed ID: 19116850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image guidance based on prostate position for prostate cancer proton therapy.
    Vargas C; Wagner M; Indelicato D; Fryer A; Horne D; Chellini A; McKenzie C; Lawlor P; Mahajan C; Li Z; Lin L; Keole S
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1322-8. PubMed ID: 18472365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal therapy for prostate cancer: pathologic basis.
    Mouraviev V; Madden JF
    Curr Opin Urol; 2009 Mar; 19(2):161-7. PubMed ID: 19188770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens.
    Huang D; Casale GP; Tian J; Wehbi NK; Abrahams NA; Kaleem Z; Smith LM; Johansson SL; Elkahwaji JE; Hemstreet GP
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1371-81. PubMed ID: 17623804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue.
    van Niekerk CG; van der Laak JA; Börger ME; Huisman HJ; Witjes JA; Barentsz JO; Hulsbergen-van de Kaa CA
    Prostate; 2009 Jan; 69(1):62-9. PubMed ID: 18780292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
    Heijmink SW; Scheenen TW; Fütterer JJ; Klomp DW; Heesakkers RA; Hulsbergen-van de Kaa CA; van Lin EN; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Jun; 42(6):420-7. PubMed ID: 17507814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.